[FDMT] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[FDMT] 4D Molecular Therapeutics, Inc.
Announcement Date
29-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -214.77%
YoY- -18.37%
Quarter Report
FDMT's Result
FDMT's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue -19 1,247 92 -977 2,030 4,531 -
PBT -32,283 -27,379 -25,083 -20,547 -16,115 -2,183 71.33%
Tax 6,728 -106 312 -4 -218 0 -
NP -32,283 -27,273 -25,083 -20,547 -16,115 -2,183 71.33%
Tax Rate - - - - - - -
Total Cost 32,264 28,520 25,175 19,570 18,145 6,713 36.86%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin 169,910.53 -2,187.09 -27,264.13 2,103.07 -793.84 -48.17 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS -0.83 -0.84 -0.93 -0.77 -1.09 -0.43 14.04%
EPS Diluted -0.83 -0.84 -0.93 -0.77 -1.09 -0.43 14.04%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.